KY19382 Accelerates Cutaneous Wound Healing Via Activation Of The Wnt/β-Catenin Signaling Pathway
July 2023
in “
International Journal of Molecular Sciences
”
New to KY19382? There is a guide in the encyclopedia. Read the guide → Studysummary This study found that KY19382, a small molecule activating the Wnt/β-catenin pathway, significantly improved wound healing by enhancing cell migration, increasing collagen and stem cell markers, and accelerating re-epithelialization and neo-epidermis formation in a murine model without causing significant cytotoxicity. Our plain-language summary of this paper — not a Tressless recommendation.
The study demonstrates that KY19382 significantly accelerates cutaneous wound healing by activating the Wnt/β-catenin signaling pathway, which is crucial for tissue regeneration. KY19382 enhances the migration and proliferation of human keratinocytes and dermal fibroblasts without significant cytotoxicity. In a murine model with 8-week-old male C3H mice (n = 6 mice/group), KY19382 outperformed controls like EGF and PTD-DBM by promoting collagen deposition, re-epithelialization, and stem cell activation, marked by CD34 and Nestin. These findings suggest that KY19382 could be a promising therapeutic agent for wound healing by targeting the Wnt/β-catenin pathway.
